Development of [ 18 F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET Agents
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Xuedan Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States. Hauptthemen laut MEDLINE: Tryptophan, Melanoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
Although various radiolabeled tryptophan analogs have been developed to monitor tryptophan metabolism using positron emission tomography (PET) for various human diseases including melanoma and other cancers, their application can be limited due to the complicated synthesis process. In this study, we demonstrated that photoredox radiofluorination represents a simple method to access novel tryptophan-based PET agents. In brief, 4-F-5-OMe-tryptophans (l/d-T13) and 6-F-5-OMe-tryptophans (l/d-T18) were easily synthesized. The 18F-labeled analogs were produced by photoredox radiofluorination with radiochemical yields ranging from 2.6 ± 0.5% to 32.4 ± 4.1% (3 ≤ n ≤ 5, enantiomeric excess ≥ 99.0%) and over 98.0% radiochemical purity. Small animal imaging showed that l-[18F]T13 achieved 9.58 ± 0.26%ID/g tumor uptake and good contrast in B16F10 tumor-bearing mice (n = 3). Clearly, l-[18F]T13 exhibited prominent tumor uptake, warranting future evaluations of its potential usage in precise immunotherapy monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
- Biomedical Research Imaging Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514, United States.
- Department of Medicine, Division of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514, United States.
ORCID-Profile: Xuedan Wu, Muyun Xu, Li Wang, Stergios J Moschos, Zibo Li
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- University of North Carolina at Chapel Hill
Zitieren
APA
Wu, X., Ma, X., Zhong, Y., Chen, W., Xu, M., Zhang, H., Wang, L., Tu, X., Han, Z., Zhao, W., Wu, Z., Moschos, S. J., & Li, Z. (2023). Development of [ 18 F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET Agents. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01544
Vancouver
Wu X, Ma X, Zhong Y, Chen W, Xu M, Zhang H, et al. Development of [ 18 F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET Agents. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01544
BibTeX
@article{Wu2023,
author = {Wu, Xuedan and Ma, Xinrui and Zhong, Yaofeng and Chen, Wei and Xu, Muyun and Zhang, He and Wang, Li and Tu, Xianshuang and Han, Zhaoguo and Zhao, Weiling and Wu, Zhanhong and Moschos, Stergios J and Li, Zibo},
title = {Development of [ 18 F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET Agents},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01544}
}
EUVIMED